abstract |
The present invention provides a diarylamine-based compound represented by General Formula (1): n n n n n n n n n n (where A 1 and A 2 each independently represent a C 6 to C 18 arylene group which may have a substituent, and A 3 and A 4 each independently represent an organic group having a cyclic imide structure which may have a substituent). |